Document Report Card

Basic Information

ID: ALA1148670

Journal: Bioorg Med Chem Lett

Title: Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.

Authors: Palmer JT, Hirschbein BL, Cheung H, McCarter J, Janc JW, Yu ZW, Wesolowski G.

Abstract: We have prepared a series of cathepsin K inhibitors bearing the keto-1,3,4-oxadiazole warhead capable of forming a hemithioketal complex with the target enzyme. By modifying binding moieties at the P1, P2, and prime side positions of the inhibitors, we have achieved selectivity over cathepsins B, L, and S, and have achieved sub-nanomolar potency against cathepsin K. This series thus represents a promising chemotype that could be used in diseases implicated by imbalances in cathepsin K activity such as osteoporosis.

CiteXplore: 16546382

DOI: 10.1016/j.bmcl.2006.03.001